checkAd
    Startseite > Aktien > Halberd > Nachrichten
    Halberd Aktie
    0,0088
     
    USD
    +10,00 %
    +0,0008 USD
    Letzter Kurs 11.05.24 Nasdaq OTC
    ISIN: US4053311092 · WKN: A118WD · SYM: HALB · USA

    Neueste Nachrichten

    Halberd's Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill
    09.05.24 · Accesswire · Halberd
    Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans
    30.04.24 · Accesswire · Halberd
    Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract
    04.04.24 · Accesswire · Halberd
    Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com
    13.12.23 · Accesswire · Halberd
    Halberd Corporation Plans to Extend Research Partnership with Mississippi State University
    15.11.23 · Accesswire · Halberd
    Hartman, CEO, and Dr. Felder, CTO of Halberd Corp, Featured on The Street Reports Podcast
    10.10.23 · Accesswire · Halberd
    Halberd's Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)
    04.10.23 · Accesswire · Halberd
    Halberd and Athena GTX Collaborate on Advanced Traumatic Brain Injury (TBI) Monitoring and Applications for Government Contracts
    20.09.23 · Accesswire · Halberd
    Astounding Early Test Results of Halberd's Traumatic Brain Injury (TBI) Project at Mississippi State University (MSU)
    06.09.23 · Accesswire · Halberd
    Halberd’s Successful Completion of Sampling Phase Marks Major Milestone for Project at Mississippi State University (MSU)
    22.08.23 · Accesswire · Halberd
    Halberd-Mississippi State University (MSU) Testing of TBI Nasal Spray Progresses
    14.08.23 · Accesswire · Halberd
    Halberd Corporation 2Q23 CEO Letter
    20.07.23 · Accesswire · Halberd